Privia Health Group, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Privia Health Group, Inc. (PRVA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.12 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- Privia Health Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 4.16M shares, a 4.13% increase year-over-year.
- Privia Health Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 3.99M shares, a 57.46% decline year-over-year.
- Privia Health Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 9.39M shares, a 77.79% increase year-over-year.
- Privia Health Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 5.28M shares, a 74.63% decline year-over-year.
- Privia Health Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 2.72M shares, a 58.91% decline from fiscal 2024.
- Privia Health Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.61M shares, a 81.28% increase from fiscal 2023.
- Privia Health Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 3.65M shares, a 76.58% decline from fiscal 2022.
- Privia Health Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 15.58M shares, a 25.45% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.12M shares 10-Q · filed 2026-08-06 | |||||||
| 2026-03-31 | 4.16M shares 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | 2.72M shares 10-K · filed 2026-02-27 | |||||||
| 2025-09-30 | 8.02M shares 10-Q · filed 2025-11-06 | |||||||
| 2025-06-30 | 4.93M shares 10-Q · filed 2026-08-06 | 8.04M shares 10-Q · filed 2025-08-07 | ||||||
| 2025-03-31 | 3.99M shares 10-Q · filed 2026-05-07 | 8.89M shares 10-Q · filed 2025-05-08 | ||||||
| 2024-12-31 | 6.61M shares 10-K · filed 2026-02-27 | 8.10M shares 10-K · filed 2025-02-27 | ||||||
| 2024-09-30 | 8.29M shares 10-Q · filed 2025-11-06 | |||||||
| 2024-06-30 | 8.72M shares 10-Q · filed 2025-08-07 | |||||||
| 2024-03-31 | 9.39M shares 10-Q · filed 2025-05-08 | |||||||
| 2023-12-31 | 3.65M shares 10-K · filed 2026-02-27 | 5.59M shares 10-K · filed 2024-02-27 | ||||||
| 2023-09-30 | 5.41M shares 10-Q · filed 2024-11-07 | |||||||
| 2023-06-30 | 6.01M shares 10-Q · filed 2024-08-08 | |||||||
| 2023-03-31 | 5.28M shares 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | 15.58M shares 10-K · filed 2025-02-27 | |||||||
| 2022-09-30 | 15.94M shares 10-Q · filed 2023-11-03 | |||||||
| 2022-06-30 | 20.20M shares 10-Q · filed 2023-08-03 | |||||||
| 2022-03-31 | 20.82M shares 10-Q · filed 2023-05-04 | |||||||
| 2021-12-31 | 20.90M shares 10-K · filed 2024-02-27 | |||||||
| 2021-09-30 | 20.35M shares 10-Q · filed 2021-11-08 | 22.52M shares 10-Q · filed 2022-11-10 | 20.41M shares 10-Q · filed 2021-11-08 | |||||
| 2021-06-30 | 20.63M shares 10-Q · filed 2021-08-09 | 23.04M shares 10-Q · filed 2022-08-11 | 20.67M shares 10-Q · filed 2021-08-09 | |||||
| 2021-03-31 | 18.22M shares 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | 18.30M shares 10-K · filed 2023-03-01 | |||||||
| 2020-09-30 | 17.95M shares 10-Q · filed 2021-11-08 | 17.98M shares 10-Q · filed 2021-11-08 | ||||||
| 2020-06-30 | 17.75M shares 10-Q · filed 2021-08-09 | 17.77M shares 10-Q · filed 2021-08-09 | ||||||
| 2020-03-31 | 17.60M shares 10-Q · filed 2021-05-28 | |||||||
| 2019-12-31 | 17.65M shares 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |